Hypereosinophilic syndrome: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 6: | Line 6: | ||
Image = | | Image = | | ||
Caption = | | Caption = | | ||
DiseasesDB = | | DiseasesDB = 34939| | ||
ICD10 = {{ICD10|D|72|1|d|70}} ([[ILDS]] D72.12) | | ICD10 = {{ICD10|D|72|1|d|70}} ([[ILDS]] D72.12) | | ||
ICD9 = {{ICD9|288.3}} | | ICD9 = {{ICD9|288.3}} | | ||
Revision as of 14:44, 21 September 2012
For patient information, click here
| Hypereosinophilic syndrome | |
| ICD-10 | D72.1 (ILDS D72.12) |
|---|---|
| ICD-9 | 288.3 |
| ICD-O: | 9964/3 |
| OMIM | 607685 |
| DiseasesDB | 34939 |
| MeSH | D017681 |
Template:Hypereosinophilic syndrome Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Hypereosinophilic syndrome from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies